NeuroPace, Inc. (NPCE)

13.98 -0.02 (-0.14%) 收市：04:00PM EDT

NeuroPace, Inc.

455 North Bernardo Avenue
Mountain View, CA 94043
United States
650-237-2700
https://www.neuropace.com

版塊: Healthcare
行業: Medical Devices
全職員工: 171

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Martha J. Morrell	Chief Medical Officer	555.87k	無	1957
Mr. Joel D. Becker	CEO, President & Director	無	無	1968
Ms. Rebecca L. Kuhn	CFO, VP of Finance & Administration and Assistant Secretary	440.92k	無	1961
Ms. Kelley Nicholas	Vice President of Sales	無	無	無
Ms. Irene Thomas	Vice President of Human Resources	無	無	1969

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

公司管治

截至 無 止，NeuroPace, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。